Market revenue in 2023 | USD 678.6 million |
Market revenue in 2030 | USD 1,295.6 million |
Growth rate | 9.7% (CAGR from 2023 to 2030) |
Largest segment | Pharmaceutical industry |
Fastest growing segment | Diagnostics |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Pharmaceutical Industry, Cosmetics And Household Products, Academic Institutes and Research Laboratories, Diagnostics, Chemicals Industry, Food Industry |
Key market players worldwide | Charles River Laboratories International Inc, SGS, Merck KGaA, Eurofins Scientific SE, Abbott Laboratories, Labcorp Holdings Inc, Evotec SE, Thermo Fisher Scientific Inc, Quest Diagnostics Inc, Agilent Technologies Inc, Catalent Inc, Danaher Corp, Bio-Rad Laboratories Inc |
Pharmaceutical industry was the largest segment with a revenue share of 43.25% in 2023. Horizon Databook has segmented the Sweden in-vitro toxicology testing market based on pharmaceutical industry, cosmetics and household products, academic institutes and research laboratories, diagnostics, chemicals industry, food industry covering the revenue growth of each sub-segment from 2018 to 2030.
In vitro toxicology testing offers a nonanimal method for personal care and cosmetic industry. It allows an effective evaluation of potential of end products and ingredients to cause eye irritation, skin irritation, skin corrosion, and other severe adverse events when used by customers.
Some of the key players operating in Sweden market are SenzaGen, Eurofins Scientific, Fujirebio, and ViruSure. The presence of a large number of market players and various strategic initiatives undertaken by them are anticipated to drive the in-vitro toxicology testing market in the country.
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account